Item 2.02 Results of Operations and Financial Condition.

On April 24, 2023, ARCA biopharma, Inc., or ARCA, issued a press release reporting financial results for the quarter ended March 31, 2023. The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.

Exhibit           Description
 Number

99.1                Press Release titled "ARCA biopharma Announces First Quarter
                  2023 Financial Results" dated April 24, 2023  .
104               Cover Page Interactive Data File. The cover page XBRL tags are
                  embedded within the inline XBRL document (contained in Exhibit
                  101).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses